FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.22-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764194016 | Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3764195015 | Velaglucerase alfa 400 unit lyophilized powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3786508014 | Velaglucerase alfa 400 unit lyophilised powder for solution for injection vial | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Product manufactured as parenteral dose form (product) | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Product containing velaglucerase alfa (medicinal product) | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. | Velaglucerase alfa (substance) | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | lyophilisat et solvant pour solution injectable | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 400 | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | This attribute specifies the numerator unit for the presentation strength of a product. | Unit | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Velaglucerase alfa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial (unit of presentation) | false | Inferred relationship | Some | ||
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Velaglucerase alfa (substance) | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | This attribute specifies the denominator unit for the presentation strength of a product. | Vial (unit of presentation) | false | Inferred relationship | Some | 1 | |
| Product containing precisely velaglucerase alfa 400 unit/1 vial lyophilized powder for conventional release solution for injection (clinical drug) | Is a | Velaglucerase alfa only product in parenteral dose form | false | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)